Key Demographic Drivers: Global Prevalence and the Burgeoning Geriatric Population
The primary growth engine for the Epilepsy Diagnosis and Treatment Market is the alarming rise in the global prevalence of epilepsy, estimated to affect approximately 50 million people worldwide. This high disease burden creates an innate and constantly increasing demand for diagnostic services, anti-epileptic drugs (AEDs), and advanced treatment solutions globally, especially as awareness...
0 Commentarii 0 Distribuiri 151 Views 0 previzualizare